Hypercoagulability Recruiting Phase Trials for Rivaroxaban (DB06228)

Also known as: Hypercoagulation / Thrombophilia / Thrombophilia (disorder) / Antithrombin III deficiency / Hypercoagulability state (finding)

IndicationStatusPhase
DBCOND0035276 (Hypercoagulability)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04736901Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19